English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 85 | Tables: 87 | Medical Care
The global market for Cell Therapy and Gene Therapy CDMO was valued at US$ 4390 million in the year 2024 and is projected to reach a revised size of US$ 15470 million by 2031, growing at a CAGR of 20.0% during the forecast period.
Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.
North American market for Cell Therapy and Gene Therapy CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Therapy and Gene Therapy CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Therapy and Gene Therapy CDMO in Clinical Stage Projects is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Therapy and Gene Therapy CDMO include Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec, He Yuan Biology, GenScript Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy and Gene Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy and Gene Therapy CDMO.
The Cell Therapy and Gene Therapy CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Therapy and Gene Therapy CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy and Gene Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza Pharmaceuticals
Thermo Fisher
catalent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Sano Biologics
Yunzhou Biology
Segment by Type
Cell Therapy
Gene Therapy
Segment by Application
Clinical Stage Projects
Commercialization Stage Projects
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy and Gene Therapy CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 Gene Therapy
1.3 Market by Application
1.3.1 Global Cell Therapy and Gene Therapy CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Stage Projects
1.3.3 Commercialization Stage Projects
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy and Gene Therapy CDMO Market Perspective (2020-2031)
2.2 Global Cell Therapy and Gene Therapy CDMO Growth Trends by Region
2.2.1 Global Cell Therapy and Gene Therapy CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Therapy and Gene Therapy CDMO Historic Market Size by Region (2020-2025)
2.2.3 Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Region (2026-2031)
2.3 Cell Therapy and Gene Therapy CDMO Market Dynamics
2.3.1 Cell Therapy and Gene Therapy CDMO Industry Trends
2.3.2 Cell Therapy and Gene Therapy CDMO Market Drivers
2.3.3 Cell Therapy and Gene Therapy CDMO Market Challenges
2.3.4 Cell Therapy and Gene Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy and Gene Therapy CDMO Players by Revenue
3.1.1 Global Top Cell Therapy and Gene Therapy CDMO Players by Revenue (2020-2025)
3.1.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Therapy and Gene Therapy CDMO Revenue
3.4 Global Cell Therapy and Gene Therapy CDMO Market Concentration Ratio
3.4.1 Global Cell Therapy and Gene Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Gene Therapy CDMO Revenue in 2024
3.5 Global Key Players of Cell Therapy and Gene Therapy CDMO Head office and Area Served
3.6 Global Key Players of Cell Therapy and Gene Therapy CDMO, Product and Application
3.7 Global Key Players of Cell Therapy and Gene Therapy CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy and Gene Therapy CDMO Breakdown Data by Type
4.1 Global Cell Therapy and Gene Therapy CDMO Historic Market Size by Type (2020-2025)
4.2 Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Type (2026-2031)
5 Cell Therapy and Gene Therapy CDMO Breakdown Data by Application
5.1 Global Cell Therapy and Gene Therapy CDMO Historic Market Size by Application (2020-2025)
5.2 Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Therapy and Gene Therapy CDMO Market Size (2020-2031)
6.2 North America Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025)
6.4 North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy and Gene Therapy CDMO Market Size (2020-2031)
7.2 Europe Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025)
7.4 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size (2020-2031)
8.2 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Therapy and Gene Therapy CDMO Market Size (2020-2031)
9.2 Latin America Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025)
9.4 Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size (2020-2031)
10.2 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Pharmaceuticals
11.1.1 Lonza Pharmaceuticals Company Details
11.1.2 Lonza Pharmaceuticals Business Overview
11.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Introduction
11.1.4 Lonza Pharmaceuticals Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.1.5 Lonza Pharmaceuticals Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Introduction
11.2.4 Thermo Fisher Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 catalent
11.3.1 catalent Company Details
11.3.2 catalent Business Overview
11.3.3 catalent Cell Therapy and Gene Therapy CDMO Introduction
11.3.4 catalent Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.3.5 catalent Recent Development
11.4 Jubilant LifeSciences
11.4.1 Jubilant LifeSciences Company Details
11.4.2 Jubilant LifeSciences Business Overview
11.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Introduction
11.4.4 Jubilant LifeSciences Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.4.5 Jubilant LifeSciences Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Introduction
11.5.4 Boehringer Ingelheim Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Details
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Introduction
11.6.4 Oxford BioMedica Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.6.5 Oxford BioMedica Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River Cell Therapy and Gene Therapy CDMO Introduction
11.7.4 Charles River Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.7.5 Charles River Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Details
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Introduction
11.8.4 WuXi AppTec Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.8.5 WuXi AppTec Recent Development
11.9 He Yuan Biology
11.9.1 He Yuan Biology Company Details
11.9.2 He Yuan Biology Business Overview
11.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Introduction
11.9.4 He Yuan Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.9.5 He Yuan Biology Recent Development
11.10 GenScript Biotech
11.10.1 GenScript Biotech Company Details
11.10.2 GenScript Biotech Business Overview
11.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Introduction
11.10.4 GenScript Biotech Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.10.5 GenScript Biotech Recent Development
11.11 Kanglong Chemical
11.11.1 Kanglong Chemical Company Details
11.11.2 Kanglong Chemical Business Overview
11.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Introduction
11.11.4 Kanglong Chemical Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.11.5 Kanglong Chemical Recent Development
11.12 Porton shares
11.12.1 Porton shares Company Details
11.12.2 Porton shares Business Overview
11.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Introduction
11.12.4 Porton shares Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.12.5 Porton shares Recent Development
11.13 Sano Biologics
11.13.1 Sano Biologics Company Details
11.13.2 Sano Biologics Business Overview
11.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Introduction
11.13.4 Sano Biologics Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.13.5 Sano Biologics Recent Development
11.14 Yunzhou Biology
11.14.1 Yunzhou Biology Company Details
11.14.2 Yunzhou Biology Business Overview
11.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Introduction
11.14.4 Yunzhou Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
11.14.5 Yunzhou Biology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Gene Therapy
Table 4. Global Cell Therapy and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cell Therapy and Gene Therapy CDMO Market Share by Region (2020-2025)
Table 8. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cell Therapy and Gene Therapy CDMO Market Share by Region (2026-2031)
Table 10. Cell Therapy and Gene Therapy CDMO Market Trends
Table 11. Cell Therapy and Gene Therapy CDMO Market Drivers
Table 12. Cell Therapy and Gene Therapy CDMO Market Challenges
Table 13. Cell Therapy and Gene Therapy CDMO Market Restraints
Table 14. Global Cell Therapy and Gene Therapy CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cell Therapy and Gene Therapy CDMO Market Share by Players (2020-2025)
Table 16. Global Top Cell Therapy and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2024)
Table 17. Ranking of Global Top Cell Therapy and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cell Therapy and Gene Therapy CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cell Therapy and Gene Therapy CDMO, Headquarters and Area Served
Table 20. Global Key Players of Cell Therapy and Gene Therapy CDMO, Product and Application
Table 21. Global Key Players of Cell Therapy and Gene Therapy CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Cell Therapy and Gene Therapy CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Pharmaceuticals Company Details
Table 47. Lonza Pharmaceuticals Business Overview
Table 48. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product
Table 49. Lonza Pharmaceuticals Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 50. Lonza Pharmaceuticals Recent Development
Table 51. Thermo Fisher Company Details
Table 52. Thermo Fisher Business Overview
Table 53. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product
Table 54. Thermo Fisher Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Recent Development
Table 56. catalent Company Details
Table 57. catalent Business Overview
Table 58. catalent Cell Therapy and Gene Therapy CDMO Product
Table 59. catalent Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 60. catalent Recent Development
Table 61. Jubilant LifeSciences Company Details
Table 62. Jubilant LifeSciences Business Overview
Table 63. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product
Table 64. Jubilant LifeSciences Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 65. Jubilant LifeSciences Recent Development
Table 66. Boehringer Ingelheim Company Details
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product
Table 69. Boehringer Ingelheim Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Oxford BioMedica Company Details
Table 72. Oxford BioMedica Business Overview
Table 73. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product
Table 74. Oxford BioMedica Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 75. Oxford BioMedica Recent Development
Table 76. Charles River Company Details
Table 77. Charles River Business Overview
Table 78. Charles River Cell Therapy and Gene Therapy CDMO Product
Table 79. Charles River Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 80. Charles River Recent Development
Table 81. WuXi AppTec Company Details
Table 82. WuXi AppTec Business Overview
Table 83. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product
Table 84. WuXi AppTec Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 85. WuXi AppTec Recent Development
Table 86. He Yuan Biology Company Details
Table 87. He Yuan Biology Business Overview
Table 88. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product
Table 89. He Yuan Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 90. He Yuan Biology Recent Development
Table 91. GenScript Biotech Company Details
Table 92. GenScript Biotech Business Overview
Table 93. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product
Table 94. GenScript Biotech Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 95. GenScript Biotech Recent Development
Table 96. Kanglong Chemical Company Details
Table 97. Kanglong Chemical Business Overview
Table 98. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product
Table 99. Kanglong Chemical Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 100. Kanglong Chemical Recent Development
Table 101. Porton shares Company Details
Table 102. Porton shares Business Overview
Table 103. Porton shares Cell Therapy and Gene Therapy CDMO Product
Table 104. Porton shares Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 105. Porton shares Recent Development
Table 106. Sano Biologics Company Details
Table 107. Sano Biologics Business Overview
Table 108. Sano Biologics Cell Therapy and Gene Therapy CDMO Product
Table 109. Sano Biologics Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 110. Sano Biologics Recent Development
Table 111. Yunzhou Biology Company Details
Table 112. Yunzhou Biology Business Overview
Table 113. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product
Table 114. Yunzhou Biology Revenue in Cell Therapy and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
Table 115. Yunzhou Biology Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Cell Therapy and Gene Therapy CDMO Picture
Figure 2. Global Cell Therapy and Gene Therapy CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell Therapy and Gene Therapy CDMO Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. Gene Therapy Features
Figure 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell Therapy and Gene Therapy CDMO Market Share by Application: 2024 VS 2031
Figure 8. Clinical Stage Projects Case Studies
Figure 9. Commercialization Stage Projects Case Studies
Figure 10. Cell Therapy and Gene Therapy CDMO Report Years Considered
Figure 11. Global Cell Therapy and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Cell Therapy and Gene Therapy CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cell Therapy and Gene Therapy CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Cell Therapy and Gene Therapy CDMO Market Share by Players in 2024
Figure 15. Global Top Cell Therapy and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy and Gene Therapy CDMO Revenue in 2024
Figure 17. North America Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 19. United States Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 23. Germany Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Share by Region (2020-2031)
Figure 31. China Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 39. Mexico Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Share by Country (2020-2031)
Figure 43. Turkey Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Cell Therapy and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Lonza Pharmaceuticals Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 47. Thermo Fisher Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 48. catalent Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 49. Jubilant LifeSciences Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 51. Oxford BioMedica Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 52. Charles River Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 53. WuXi AppTec Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 54. He Yuan Biology Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 55. GenScript Biotech Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 56. Kanglong Chemical Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 57. Porton shares Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 58. Sano Biologics Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 59. Yunzhou Biology Revenue Growth Rate in Cell Therapy and Gene Therapy CDMO Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
